| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | Chevallard Daniel R. | Chief Financial Officer | May 14, 2024 | Buy | $15.68 | 3,188 | 49,988 | 3,188 | May 15, 2024, 04:13 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 27, 2024 | Sale | $0.73 | 3,405 | 2,493 | 102,306 | Feb 27, 2024, 07:54 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 28, 2023 | Sale | $0.50 | 3,720 | 1,860 | 98,822 | Nov 28, 2023, 07:06 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Aug 28, 2023 | Sale | $1.45 | 3,512 | 5,092 | 95,653 | Aug 29, 2023, 06:47 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | May 25, 2023 | Sale | $1.42 | 3,635 | 5,160 | 92,277 | May 26, 2023, 07:29 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 27, 2023 | Sale | $1.68 | 3,599 | 6,051 | 89,023 | Feb 28, 2023, 06:22 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 28, 2022 | Sale | $2.72 | 3,532 | 9,606 | 85,733 | Nov 29, 2022, 05:33 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Aug 26, 2022 | Sale | $4.02 | 3,655 | 14,679 | 82,376 | Aug 29, 2022, 09:14 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | May 26, 2022 | Sale | $1.90 | 3,596 | 6,836 | 79,142 | May 27, 2022, 05:27 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Feb 28, 2022 | Sale | $2.78 | 3,998 | 11,112 | 75,849 | Mar 01, 2022, 09:10 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 26, 2021 | Sale | $4.80 | 3,254 | 15,621 | 77,283 | Nov 29, 2021, 07:48 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Nov 29, 2021 | Sale | $4.82 | 4,325 | 20,843 | 72,958 | Nov 29, 2021, 07:48 PM | |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | Sep 28, 2021 | Option Exercise | $0.90 | 10,000 | 9,000 | 66,760 | Sep 29, 2021, 06:04 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Jul 01, 2019 | Sale | $1.31 | 2,669 | 3,500 | 77,870 | Jul 02, 2019, 05:41 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | May 15, 2019 | Sale | $1.41 | 10,000 | 14,089 | 80,539 | May 16, 2019, 05:21 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Apr 01, 2019 | Sale | $0.98 | 3,253 | 3,192 | 9,372 | Apr 03, 2019, 12:00 AM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Feb 05, 2019 | Option Exercise | $0.95 | 30,000 | 28,500 | 34,578 | Feb 06, 2019, 04:50 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Jul 25, 2017 | Buy | $0.91 | 54,945 | 50,000 | 59,415 | Jul 25, 2017, 06:07 PM |
Menu